Lunch Program: Lifetime Management Considerations with EvolutTM FX for Patients with Aortic Stenosis – Balancing Patient Needs with Clinical Decision Making
Sponsored by Medtronic
This symposium is a case-based lesson of lifetime management considerations utilizing EvolutTM FX when planning for your TAVR patients. The speakers are experienced TAVR implanters and the discussion will be a reflection on what they’ve learned while using FX and its potential for future applicability to help the mounting challenge physicians may experience in deciding which patients are appropriate for TAVR. Case-based discussion will be based around highlighting FX ease of use, patient selection, durability data, and predictability with the FX procedure. Presentations will be accompanied by question-and-answer periods with an emphasis on audience participation and discussion.
Program Introduction
Paul Dennis Mahoney, M.D., FSCAI, ECU Health, Greenville, NC and Anene Ukaigwe, M.D., FSCAI, University Hospitals, Harrington Heart and Vascular Institute, Cleveland, Pepper Pike, OH